Steroid Use in Pericardial Effusion Management

Introduction to Steroid Therapy

The European Society of Cardiology recommends that steroids are not first-line therapy for pericardial effusion and should be reserved for specific clinical scenarios, including tuberculous pericarditis, contraindication or failure of NSAIDs and colchicine, autoimmune disease, or patients on anticoagulation where NSAIDs pose high bleeding risk 1, 2, 3

The European Society of Cardiology recommends NSAIDs (aspirin or ibuprofen) plus colchicine as the first-line therapy when pericardial effusion is associated with inflammation/pericarditis 1, 4
For isolated effusion without inflammation, treatment should target the underlying etiology, as NSAIDs and corticosteroids are generally ineffective 4
Pericardiocentesis is indicated for tamponade, symptomatic large effusions unresponsive to medical therapy, or suspected bacterial/neoplastic causes 4, 5

Adjunctive steroids may be considered in HIV-negative patients with tuberculous pericarditis to reduce mortality and need for pericardiectomy, with a Class IIb recommendation 1, 2
Steroids should be avoided in HIV-positive patients with tuberculous pericarditis due to increased risk of malignancy 1, 2
When used, prednisone 1-2 mg/kg/day is required for tuberculous pericarditis, with maintenance of initial dose for 5-7 days, then taper over 6-8 weeks 6, 7
Corticosteroids are contraindicated in tuberculous pericarditis except as adjunct to anti-tuberculous treatment 6, 7
Low-dose corticosteroids (prednisone 0.2-0.5 mg/kg/day) should be considered when NSAIDs/colchicine are contraindicated or have failed 1, 8, 3

Steroids are absolutely contraindicated as first-line therapy for acute pericarditis and pericardial effusion, with a Class III recommendation 1, 8
Never use steroids in uremic pericarditis except when intensive dialysis is ineffective (Class IIb, only after dialysis optimization) 9
Exclude infectious causes before initiating steroids, particularly bacterial and fungal pericarditis 1

Initial dose: prednisone 0.2-0.5 mg/kg/day for low-dose approach (preferred for non-TB cases) 1, 8, 3
For tuberculous pericarditis: 1-2 mg/kg/day due to rifampicin interaction 6, 7, 3
Maintain initial dose until symptoms resolve and CRP normalizes 8, 3
Taper schedule:
If symptoms recur during taper, return to last effective dose for 2-3 weeks before resuming slower taper 3

Introduce colchicine or NSAIDs toward end of steroid taper and continue for at least 3 months after completing steroids 3
Add azathioprine (75-100 mg/day) or cyclophosphamide if inadequate response to steroids alone 3
Bone protection is mandatory: calcium 1,200-1,500 mg/day and vitamin D 800-1,000 IU/day for all patients on glucocorticoids 3
Consider bisphosphonates for men ≥50 years and postmenopausal women on long-term therapy 3

The 2015 ESC Guidelines represent the most recent and authoritative recommendations, superseding the 2004 guidelines 1, 2, 6, 7
The evidence for steroids in tuberculous pericarditis shows promising trends but remains inconclusive (Class IIb, Level C evidence) 1, 2